Bigul

Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Investor Presentation

Announcement under Regulation 30 of SEBI (LODR) Regulation, 2015 - Investor Meeting and Road Show
20-11-2023

Orchid Pharma's Q2 net surges, company to manufacture cefidorocol

The sublicensing agreement with Shionogi, Japan, facilitated through GARDP, will allow Orchid to produce this crucial product
14-11-2023

Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Announcement under Regulation 30 (LODR) - Earning Call Transcript
10-11-2023

Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Announcement under Regulation 30 (LODR)-Investor Call Audio Recording
06-11-2023

Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Investor Presentation

Announcement under Regulation 30 of SEBI (LODR) Regulation, 2015 - Investor Presentation
06-11-2023

Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Announcement under Regulation 30 of SEBI (LODR) Regulation, 2015 - Monitoring Agency Report
06-11-2023

Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Announcement under Regulation 30 of SEBI (LODR) Regulation, 2015 - Newspaper Publication
06-11-2023

Orchid Pharma Ltd - 524372 - Approval Of Unaudited (Standalone & Consolidated) Financial Results For The Period Ended September 30, 2023

Approval of Unaudited (Standalone & Consolidated) Financial Results for the period ended September 30, 2023
04-11-2023

Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
02-11-2023

Orchid Pharma Ltd - 524372 - Announcement Under Regulation 30 Of SEBI (LODR) Regulation, 2015 - Update

Announcement under Regulation 30 of SEBI (LODR) Regulation, 2015 - Update
01-11-2023